What Is Cell Therapy?

Matthew “Matt” Feshbach is the founder and CEO of AMBROSE Cell Therapy. Established in 2018, AMBROSE Cell Therapy responded to a need for more technologically diverse treatment routes for no-option patients. Matthew Feshbach wanted the company's mission to be on improving symptoms, function, and quality of life in people with chronic degenerative diseases through adult stem cell therapy.

Cell therapy (CT) is a form of regenerative medicine seeing much interest in recent years. It encompasses a variety of processes and technologies that use human cells to repair damaged tissue in the body. For most of these procedures, laboratory researchers begin by cultivating stem cells and then differentiating them into specific cell types, such as heart muscle cells, blood cells, or nerve cells. Following that, the specialized cells can be put into a person. For instance, an individual with cardiac problems may have cells injected directly into the heart muscle. These transplanted healthy heart muscle cells could potentially contribute to the healing of damaged heart muscle.

Cell treatments may be used to treat cancer, autoimmune diseases, urinary issues, and infectious diseases. They have also shown promise in repairing damaged cartilage in joints and spinal cord injuries. Some forms of cell therapy may even assist patients with neurological diseases.